Elsevier Inc.

SHERPA: Unknown

People

  1. Rusch
    Rusch
  2. Ginsberg
    Ginsberg
  3. Kris
    Kris
  4. Dunne
    Dunne
  5. Holodny
    Holodny
  6. Janjigian
    Janjigian
  7. Miller
    Miller
  8. Moskowitz
    Moskowitz
  9. Riely
    Riely
  10. Schwartz
    Schwartz

Groups

  1. Body Imaging Service (3)
  2. Radiology, Department of (3)
  3. Surgery (3)
  4. Department of Medicine (2)
  5. Solid Tumor Oncology Division (2)
  6. Thoracic Oncology (2)
  7. Advanced Practice Providers (1)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
  9. Biostatistics Service (1)
  10. Epidemiology and Biostatistics (1)
Search Within
  1. "Lee Krug"
  2. "Journal of Thoracic Oncology"
  3. "2009"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (1)
Groups
  1. Body Imaging Service (3)
  2. Radiology, Department of (3)
  3. Surgery (3)
  4. Department of Medicine (2)
  5. Solid Tumor Oncology Division (2)
  6. Thoracic Oncology (2)

More Groups

People
  1. Lee Krug (7)
  2. Raja Flores (3)
  3. Valerie Rusch (3)
  4. Benjamin Laser (2)
  5. Kenneth Rosenzweig (2)
  6. Leanne Pereira (2)

More People

Years
  1. 2009 (7)
Publications
  1. Journal of Thoracic Oncology (7)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Measurement of tumor volumes in patients with malignant pleural mesothelioma (MPM) correlates with prognosis
    Meeting Abstract

    Zhao, B. S.; Krug, L. M.; Liu, F.; Guo, P.; Ishill, N. M.; Moskowitz, C. S.; Rusch, V. W.; Flores, R. M.; Schwartz, L. H.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Feasibility of pleural intensity-modulated radiation therapy (IMRT) for malignant pleural mesothelioma
    Meeting Abstract

    Rosenzweig, K.; Krug, L.; Laser, B.; Yorke, E.; Flores, R.; Brown, A.; Rusch, Valerie W
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Phase 1 trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib
    Meeting Abstract

    Riely, G. J.; Janjigian, Y. Y.; Pereira, L. K.; Azzoli, C. G.; Pietanza, M. C.; Krug, L. M.; Rizvi, N. A.; Kris, M. G.; Ginsberg, M. S.; Pao, W.; more...
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Phase II study of temozolomide for relapsed sensitive or refractory small cell lung cancer
    Meeting Abstract

    Pietanza, M. C.; Pereira, L.; Dunne, M.; Travis, W. D.; Chan, T. A.; Ginsberg, M. S.; Holodny, A.; Kris, M. G.; Krug, L. M.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • HDAC inhibitors
    Meeting Abstract

    Krug, L. M.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Confirmation of the reliability and validity of lung cancer symptom scale for patients with malignant pleural mesothelioma: Comparison of chemotherapy-pretreated versus chemotherapy-naive patient populations
    Meeting Abstract

    Arduino, J. M.; Kindler, H. L.; Hollen, P. J.; Sun, X.; Baas, P.; Bucci, M. E.; Lubiniecki, G. M.; Hershock, D. M.; Krug, L. M.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Patterns of local and nodal failure in malignant pleural mesothelioma after extrapleural pneumonectomy and photon-electron radiotherapy
    Journal Article

    Gupta, V.; Krug, L. M.; Laser, B.; Hudka, K.; Flores, R.; Rusch, V. W.; Rosenzweig, K. E.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save